Evaluation of safety and efficacy of PROMETRIUM [progesterone] capsules in induction of secretory conversion of endometrium and withdrawal bleeding in subjects with secondary amenorrhea.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2010
At a glance
- Drugs Conjugated estrogens; Progesterone
- Indications Amenorrhoea
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 03 Nov 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual patient number (240) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History